Emma Andrus, Editor

This review of the latest dermatologic studies includes insights into comorbidities, innovative therapies, and ultrasound for HS.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Researchers reported that propranolol initiation for infantile hemangiomas in pediatric patients is safe, with no significant complications, suggesting reduced need for intensive monitoring.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Merz Aesthetics' global study highlights how aesthetic treatments boost self-confidence, well-being, and empower individuals, transforming self-care practices.

Ustekinumab-kfce is available for the treatment of chronic autoimmune conditions like Crohn’s disease, ulcerative colitis, and plaque psoriasis.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The phase 3 clinical trial investigating delgocitinib cream for adolescents with moderate to severe CHE met its primary and key secondary endpoints.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

A dermatology expert panel confirms IGSRT as a safe, effective first-line treatment for select nonmelanoma skin cancer cases.

Phillips discusses Merz Aesthetics' recent research, which highlights how aesthetic treatments boost confidence, self-perception, and emotional well-being.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

VYNE has initiated a phase 1b trial for its oral BD2-selective BET inhibitor.

This review of the latest dermatologic studies includes insights into scuba diving's dermatological impacts, the impact of COVID-19 and vaccination on dermatological immune-mediated inflammatory diseases, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Merz Aesthetics' global study reveals that aesthetic treatments boost self-confidence, social well-being, and self-perception beyond physical appearance.

Jonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Jonathan Zalevsky, PhD, discusses the fundamentally different path of Rezpeg compared with existing IL-4 and IL-13 inhibitors in atopic dermatitis.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Zalevsky shares insights into the implications of the designation and what it may mean for Rezpeg's development timeline.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This review of the latest dermatologic studies includes insights into endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa; forms of hair loss among individuals with anxiety disorder; and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Lisa Weiss, MMSc, PA-C, and colleagues offered insights on managing severe atopic dermatitis cases with biologics, nonsteroidal treatments, and strategies for addressing physical and emotional impacts.

Explore the top headlines of the week including Allergan Aesthetics' new AA Signature program, the launch of EltaMD's new UV Skin Recovery broad spectrum SPF 50 face sunscreens, and more.

Swanson shared strategies for treating rural dermatology patients at MOPD 2025, emphasizing effective initial care, the role of telehealth, and practical treatments.

Michael Gold, MD, explored microneedling innovations, pulse wave technology for pigmentation, and the aesthetic effects of GLP-1 receptor agonists, including "Ozempic face" and skin laxity.